CML is caused by a chromosomal translocation leading to the Philadelphia chromosome (Ph) that generates the BCR-ABL oncogene, which produces, in turn, the chimeric oncoprotein BCR-ABL with high tyrosine kinase (TK) activity [1]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.